A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year Olds

Clinical trial NCT06700148 · COMPLETED

Trial details

NCT number: NCT06700148
Sponsor: CanSino Biologics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Meningitis

Start date: 2024-12-14
Primary completion: 2025-02-19
Enrollment: 840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.